Showing 1 - 1 results of 1 for search 'Gostkorzewicz J', query time: 0.02s Refine Results
  1. 1
    Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain

    Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain by Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A

    Published 2018-11-01
    Get full text
    Article

Search Tools: